My clinical activity mainly dedicated to people with glaucoma. I have surgical expertise on complex glaucomas and cataracts.

With my academic career I am trying to improve health outcomes of people with eye diseases by investigating the effectiveness, safety and efficiency of new technologies (e.g., treatments, diagnostic tests, models of eye care).

I have received over £15m of non-commercial research funds.

I am Chief Investigator of several publicly funded trials, including EAGLE, GATE, GRIP, ACE and iTRAC (co-CI) glaucoma studies, and CHAMP-UK, on myopia. I am co-applicant of TAGS and GLAURIOUS (glaucoma studies) and a number of trials on diabetic retinopathy and age-related macular degeneration.

I have authored over 250 papers. My current Scopus h-index is 46. I have edited four books.

Current leadership positions:

• chair of the Scientific Committee of the European Glaucoma Society
• chair of the NIHR CRN Clinical Study Group for glaucoma (UK)
• member of the NIHR-HTA Prioritisation Committee (UK)
• member of the NICE Interventional Procedures Advisory Committee (UK)
• member of the Development Group for the WHO Package of Glaucoma Interventions
• member of the Executive Management Committee of Evidence Synthesis Ireland
• editor of the European Glaucoma Society Guidelines (5th edition, 2020)

Recent special honours:

• King James IV Professorship by the Royal College of Surgeons of Edinburgh (2020)
• American Academy of Ophthalmology Secretariat Award (2020)

Steven J. Gedde, MD is Professor of Ophthalmology and Vice Chair of Education at the Bascom Palmer Eye Institute. He received his medical degree from Vanderbilt University School of Medicine. Dr. Gedde completed his residency training in ophthalmology at Wills Eye Hospital, where he also served as Chief Resident. He pursued a clinical glaucoma fellowship at the Bascom Palmer Eye Institute.

Dr. Gedde has lectured nationally and internationally. He has authored or coauthored more than 400 articles, book chapters, and abstracts. He is Editor of the second edition of Curbside Consultation in Glaucoma: 49 Clinical Questions, and he has served on the Editorial Boards for Ophthalmology, Journal of Academic Ophthalmology, EyeNet, Ocular Surgery News, Ophthalmology Management, and EyeWorld. Dr. Gedde has been listed among America’s Top Doctors, Best Doctors in America, America’s Best Ophthalmologists, Florida Super Doctors, and Ophthalmologist Power List. He received an Achievement Award in 2006, Senior Achievement Award in 2012, Life Achievement Award in 2022, and Secretariat Awards in 2017 and 2021 from the American Academy of Ophthalmology. He served as the Residency Program Director at the Bascom Palmer Eye Institute from 1999 to 2021. He was selected as the Excellence in Health Care Educator of the Year in 2009, and he received the Straatsma Award for Excellence in Resident Education in 2016. Dr. Gedde is a member of the American Ophthalmological Society. He has served on the Board of Directors of the American Glaucoma Society and the American Board of Ophthalmology. He is Chair of the Glaucoma Preferred Practice Pattern Panel. Dr. Gedde is a study chairman for the Tube Versus Trabeculectomy (TVT) Study and Primary Tube Versus Trabeculectomy (PTVT) Study, multicenter randomized clinical trials comparing tube shunt surgery and trabeculectomy with mitomycin C.

Dr. Hutnik is Professor and Chair in the Department of Ophthalmology at the Schulich School of Medicine and Dentistry, Western University, and Ophthalmologist-in-Chief at the Ivey Eye Institute in London, Ontario, Canada. She holds the inaugural Marcel and Louise Brunette Chair in Ophthalmology at Western. She is the Chair of the Governing Committee of the Academic Medical Association of Southwestern Ontario (AMOSO), the Academic Representative of the Eye Physicians and Surgeons of Ontario (EPSO), as well as a Board member of the Glaucoma Research Society of Canada. Her major research interest is focused on the pathophysiology and management of glaucoma. She continues to have keen interest in the development of novel and/or optimization of existing treatments for patients with glaucoma. Believing strongly in collaborative models of eye care she is proud to be the co-creator of the London and District Interprofessional Model of Care (LDIM) aimed at improving access to care for patients with glaucoma. In 2023 she was elected into the fellowship of the Canadian Academy of Health Sciences which is recognized as one of the highest honors granted to scholars in Canada.

Dr. Lim is Professor of Ophthalmology in the Department of Ophthalmology & Vision Sciences at the University of California, Davis in Sacramento, California. She is the Vice Chair and Medical Director of the UC Davis Eye Center at the newly opened Ernest E. Tschannen Eye Institute which is a world-class facility providing integrated eye care and research discoveries in vision. Her clinical work focuses on the specialty care of glaucoma patients. She has a special interest in health information technology and served as the Co-Chair of the American Academy of Ophthalmology’s (AAO) Medical Information Technology Committee. Dr. Lim’s publications in this area include electronic health record (EHR) adoption, the financial impact of EHRs, and documentation integrity with the use of EHRs. In addition, she conducts research in glaucoma with topics in optic nerve imaging, personality type in glaucoma patients, and glaucoma surgical treatments. Dr. Lim contributes to the field of ophthalmology and has been a member of the AAO’s Preferred Practice Pattern writing committee, served as an oral examiner for the American Board of Ophthalmology, was inducted into the American Ophthalmological Society, and has been Surgery Day Co-Chair and is the current Program Chair for the American Glaucoma Society Annual meeting.

Dr. Arsham Sheybani completed his medical degree with honors (AOA) at Washington University School of Medicine in St. Louis. He then completed his residency in Ophthalmology at Washington University in St. Louis and was selected to remain on faculty as Chief Resident. During that year, Dr. Sheybani was responsible for ophthalmologic trauma and emergencies as well as all adult inpatient ophthalmology consultations at Barnes Jewish Hospital. He then completed a fellowship with Ike Ahmed in Glaucoma and Advanced Anterior Segment Surgery in Toronto, Canada. He subsequently returned to Washington University School of Medicine as faculty in the Department of Ophthalmology and Visual Sciences where he serves as Residency Program Director. He is currently involved in device design aiming to make glaucoma surgery safer. He is also developing biomarkers for the diagnosis and monitoring of Primary Open Angle and Pseudoexfoliation Glaucoma. He is an avid surgical teacher, winning the resident selected faculty teaching award early in his career and he was honored by the American Glaucoma Society as the Surgery Day Lecturer. His true passion remains in serving as the glaucoma and anterior segment surgery fellowship director.

Professor Aung Tin is Academic Chair and Chief Executive Officer of Singapore National Eye Centre (SNEC), where he is a clinician scientist ophthalmologist at the Glaucoma Department.

Professor Aung’s research has secured more than US$20 million in competitive research grant funding, he is currently the Lead PI of the Large Collaborative Grant (LCG), “Tackling and Reducing Glaucoma Blindness with Emerging Technologies (TARGET), a $25 million multi-disciplinary and multicenter program grant awarded by the National Medical Research Council, Singapore in 2022. Prof Aung was awarded the Nakajima Award (2007) and De Campo Award (2013) by the Asia Pacific Academy of Ophthalmology, the Alcon Research Institute Award (2013), the Singapore Translational Research (STaR) Investigator Award (2014, and 2020), the Robert Ritch Award for Excellence and Innovation in Ophthalmology by the Glaucoma Foundation (2017), as well as numerous other awards.

Professor Aung currently has more than 700 publications including 15 major papers in Nature Genetics, JAMA and Lancet. He has delivered more than 100 Invited Lectures at international meetings. He is on the Editorial Board of 7 journals (including Ophthalmology, Progress in Retinal and Eye Research, Ophthalmology Glaucoma, Eye and Graefe’s Archive for Clinical Exp Ophthalmology; and a regular reviewer for more than 20 journals.

Professor Aung was President of the World Glaucoma Association from 2016-2017, and also serves as Board Member of the WGA and Asia Pacific Glaucoma Society. He was President of the College of Ophthalmologists of Singapore from 2012-2014 and President of the Singapore Society of Ophthalmology from 2009-2011.